SURPASS-2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 5 of 5 of this archive, newest first.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The route did not close because of a rule about peptides.
A proper account of an operation that existed, and of what closing it cost.
Grading six widely repeated claims against the studies actually behind them.
A flag is a probability statement about a population. It is not a statement about the person holding the printout.
We asked twenty companies three questions about stability data and print every answer, refusal and non-response.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
The observation that closes a facility is rarely the dramatic one.